Breaking news

Tesla’s Troubles Deepen as Wall Street Slashes Forecasts and Stock Crashes Again

by THEFUTURE.TEAM

March 18, 2025

Tesla’s stock took another hit on Monday, plunging nearly 5% to $238, making it the worst-performing stock among S&P 500 companies valued over $100 billion. While the broader market continued its recovery, Tesla’s downward spiral intensified, driven by weakening sales, geopolitical risks, and declining brand perception.

Wall Street Turns On Tesla

Investment firm Mizuho cut its price target for Tesla by $85, bringing it down to $430, while slashing its 2025 vehicle delivery forecast from 2.3 million to 1.8 million—a 20% drop. The revision comes amid:

Follow THE FUTURE on LinkedIn, Facebook, Instagram, X and Telegram

Plunging sales in key markets: U.S. sales fell 2%, China sales collapsed 49%, and German sales plunged 76%, even as local EV markets grew significantly.
Intensifying competition: Chinese automakers, buoyed by aggressive pricing and government incentives, are rapidly eroding Tesla’s dominance.
A fractured brand: Tesla’s reputation is suffering, particularly in Europe, where Elon Musk’s political views have alienated consumers.

Mizuho’s downgrade aligns with other Wall Street powerhouses, including Goldman Sachs, JPMorgan, and UBS, all of which have lowered their expectations for Tesla’s future performance.

A Brand In Crisis?

JPMorgan analysts issued a stark warning last week: “We can hardly find an analog in the history of the automotive industry where a brand has lost so much value in such a short period.” Tesla’s weakening brand perception in the U.S. and Europe is being compounded by Musk’s increasingly public political stance, particularly in Germany, where Tesla’s market share has collapsed.

Adding to Tesla’s challenges, the Trump administration’s aggressive tariff policies are now threatening its core business. Tesla recently urged the U.S. Trade Representative to reconsider the timeline of tariffs, warning that certain key EV components are difficult or impossible to source domestically.

The Big Picture: A Tumbling Stock, A Shrinking Fortune

Tesla’s stock has now lost 41% of its value since the start of the year, making it the second-biggest loser on the S&P 500. Despite Monday’s drop, Tesla shares are still up 7% from last week, when the company suffered its worst one-day decline in over four years—a staggering 15% plunge amid fears of economic instability.

For Elon Musk, the financial blow has been severe. While he remains the world’s richest person with a net worth of $329 billion, his fortune has shrunk by more than $130 billion since Tesla’s stock peaked at $480 per share in December.

What’s Next For Tesla?

Tesla’s future now hinges on multiple fronts—from rebuilding its brand and stabilizing global sales to navigating an increasingly hostile regulatory and economic environment. With Wall Street turning bearish, competition heating up, and Musk’s political entanglements adding uncertainty, Tesla’s next moves could determine whether this is a temporary setback or the start of a long-term decline.

The Future Forbes Realty Global Properties

Cyprus: A Global Leader in Longevity and Healthcare Efficiency

by News Editor

May 9, 2025

In an eye-opening study conducted by renowned universities Brown and Harvard, Cyprus emerges as a global leader in longevity while maintaining low healthcare expenditures. The study, led by Cypriot professor Irini Papanikola, uncovers insightful data on Cyprus’s healthcare efficiency.

Key Findings

Published in the prestigious Journal of the American Medical Association Internal Medicine, the study highlights that Cyprus boasts some of the lowest mortality rates among high-income countries while ensuring affordable healthcare. This research has drawn significant attention, featured in media outlets across America and Europe.

Understanding Avoidable Mortality

The study examines avoidable mortality (deaths preventable through timely healthcare) across U.S. states and 40 high-income countries from 2009 to 2021. Remarkably, Cyprus presents some of the lowest avoidable mortality rates, showcasing the efficiency of its healthcare system even amid global challenges such as the COVID-19 pandemic.

Trends and Challenges

From 2009 to 2019, most high-income countries saw a decrease in avoidable mortality; however, this trend reversed for many, including Cyprus, during the pandemic years. The findings emphasize the critical role of robust public health systems in sustaining positive health outcomes.

The Path Forward

Despite the pandemic, Cyprus’s overall performance remains commendable. To achieve success, experts suggest addressing broader health determinants, focusing on preventive measures like road safety and mental health support through collaborative efforts.

Conclusion

Overall, Cyprus stands out as a beacon of healthcare efficiency, managing to reduce avoidable mortality with relatively low costs. This achievement underscores the country’s adeptness in providing high-quality healthcare, although continued research into population needs is vital for ongoing improvements.